President Trump’s administration proposed a 50% U.S. quota increase at the IMF, equivalent to $55 billion, to support China’s struggling loans. The plan, included in the fiscal 2027 budget request, aims to rescue China’s financial sector but faces Senate resistance. Xi Jinping’s government has already drawn criticism for its handling of non-performing loans, with analysts warning of broader economic risks. Critics argue the move could deepen U.S. fiscal deficits while shifting IMF influence toward Beijing.

The quota hike, which the U.S. last proposed in 2026, would allow Washington to allocate more funds to the IMF’s lending programs. China’s bad loans—estimated at over $1 trillion—stem from infrastructure and real estate collapses, threatening global supply chains. IMF officials have urged Beijing to implement reforms, but Trump’s proposal prioritizes immediate liquidity over structural fixes. The Senate’s previous rejection of a similar 2026 plan highlights partisan divides over foreign aid.

Approval could reshape U.S.-China economic dynamics, as Beijing gains leverage in international finance. A $55 billion infusion might stabilize China’s markets temporarily but risks enabling further debt accumulation. Meanwhile, U.S. lawmakers warn the move could trigger inflationary pressures and undermine domestic fiscal priorities. The IMF’s stance remains neutral, though it cautions that unconditional aid without reforms could exacerbate systemic vulnerabilities.

Markets reacted cautiously to the proposal, with traders monitoring potential impacts on U.S. Treasury yields and China’s yuan. While the White House frames the plan as a “stabilization tool,” experts stress that lasting solutions require addressing China’s corporate governance gaps and regulatory laxity. The debate underscores tensions between short-term aid and long-term economic health, with global investors weighing risks to emerging markets and geopolitical alliances.